Ensemble of hybrid neural network learning approaches for designing pharmaceutical drugs
暂无分享,去创建一个
[1] Ajith Abraham,et al. Neuro Fuzzy Systems: Sate-of-the-Art Modeling Techniques , 2001, IWANN.
[2] John Hallam,et al. Artificial intelligence and robotics in high throughput post-genomics. , 2005, Drug discovery today.
[3] Frank R. Burden,et al. Bayesian neural nets for modeling in drug discovery , 2004 .
[4] Heather J. Ruskin,et al. Probabilistic models for drug dissolution. Part 1. Review of Monte Carlo and stochastic cellular automata approaches , 2006, Simul. Model. Pract. Theory.
[5] Ajith Abraham,et al. Engineering Drug Design Using a Multi-Input Multi-Output Neuro-Fuzzy System , 2006, 2006 Eighth International Symposium on Symbolic and Numeric Algorithms for Scientific Computing.
[6] Tim Hesterberg,et al. Bootstrap Methods and Permutation Tests* 14.1 the Bootstrap Idea 14.2 First Steps in Using the Bootstrap 14.3 How Accurate Is a Bootstrap Distribution? 14.4 Bootstrap Confidence Intervals 14.5 Significance Testing Using Permutation Tests Introduction , 2004 .
[7] Tamás Kiss,et al. From electric patterns to drugs: perspectives of computational neuroscience in drug design. , 2006, Bio Systems.
[8] R. W. Hansen,et al. The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.
[9] Weiliang Zhu,et al. New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery , 2006, Drug Discovery Today: Technologies.
[10] Robert Fullér,et al. Multiobjective optimization with linguistic variables , 1998 .
[11] S. Agatonovic-Kustrin,et al. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.
[12] GuanHua Chen,et al. A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors. , 2006, Journal of molecular graphics & modelling.
[13] P. Érdi,et al. Computational neuropharmacology: dynamical approaches in drug discovery. , 2006, Trends in pharmacological sciences.
[14] M. Møller. A Scaled Conjugate Gradient Algorithm for Fast Supervised Learning , 1990 .
[15] Bernard F. Buxton,et al. Drug Design by Machine Learning: Support Vector Machines for Pharmaceutical Data Analysis , 2001, Comput. Chem..
[16] Tae Gyu Chang,et al. Evolving Neural Networks for Pharmaceutical Research , 2006, 2006 International Conference on Hybrid Information Technology.
[17] Abby L. Parrill,et al. Evolutionary and genetic methods in drug design , 1996 .
[18] Martin Fodslette Meiller. A Scaled Conjugate Gradient Algorithm for Fast Supervised Learning , 1993 .
[19] Jure Zupan,et al. Optimization algorithms and natural computing in drug discovery. , 2004, Drug discovery today. Technologies.
[20] Philip Doble,et al. Chemical profiling and classification of illicit heroin by principal component analysis, calculation of inter sample correlation and artificial neural networks. , 2005, Talanta.
[21] William J Welsh,et al. Shape Signatures: speeding up computer aided drug discovery. , 2006, Drug discovery today.
[22] Harvey Goldstein,et al. A nonparametric bootstrap for multilevel models , 2002 .
[23] Abdelhak M. Zoubir,et al. Bootstrap Techniques for Signal Processing: Bootstrap M atlab Toolbox , 2004 .
[24] Yixin Chen,et al. Application of artificial neural networks in the design of controlled release drug delivery systems. , 2003, Advanced drug delivery reviews.
[25] K. Stewart,et al. Drug Guru: a computer software program for drug design using medicinal chemistry rules. , 2006, Bioorganic & medicinal chemistry.
[26] Christer Carlsson,et al. Multiobjective optimization with linguistic variables , 1998 .
[27] James Kennedy,et al. Particle swarm optimization , 1995, Proceedings of ICNN'95 - International Conference on Neural Networks.
[28] E. Mizutani,et al. Neuro-Fuzzy and Soft Computing-A Computational Approach to Learning and Machine Intelligence [Book Review] , 1997, IEEE Transactions on Automatic Control.
[29] Kozo Takayama,et al. Neural network based optimization of drug formulations. , 2003, Advanced drug delivery reviews.
[30] Ana Barat,et al. Probabilistic models for drug dissolution , 2006 .
[31] Johann Gasteiger,et al. Neural networks and genetic algorithms in drug design , 2001 .